2024 was characterized by continuity for INTEGRA Biosciences. With sales of CHF 156 million, the company remained at the previous year’s level despite a difficult first quarter. Compared to the period before the COVID-19 pandemic, the company has doubled in size, underlining its sustainable growth. Agility and growth in a challenging market environment The market […]
BC Platforms is a partner in BRECISE (Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement), a five-year multidisciplinary research initiative co-funded by the Innovative Health Initiative (IHI) under the Horizon Europe programme. The project officially launched in Madrid on March 20, 2025, and runs from January 1, 2025, through 2029. What Is […]
Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]
Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics’ recently approved CAR T therapy AUCATZYL® SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL® , a recently approved CAR T therapy. Agilent’s advanced cell analysis instrumentation, specifically the xCELLigence Real-Time Cell Analysis (RTCA) technology, […]
Shimadzu Corporation, a leader in innovative mass spectrometry solutions, is proud to announce that our entire family of benchtop MALDI-TOF Mass Spectrometers, the MALDI-8000 series, has received the prestigious ACT Ecolabel from My Green Lab. This certification underscores our commitment to sustainability and environmental responsibility in scientific research and laboratory practices. ACT provides clarity in […]
Facility in Gliwice, Poland to boost biopharma manufacturers’ efficiency and speed to market of therapies RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor’s Scientific Advisory Board, will present highlights of the recently completed […]
Scientist recognized for pioneering advances in bioprocess development and biomanufacturing SANTA CLARA, Calif.— Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski, an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of […]
BOSTON, MA, and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOPHiA DDM™. This achievement solidifies SOPHiA GENETICS as the gold-standard provider of actionable insights for patient care, applying AI capabilities […]
Grant allows ChromaTan and Landmark Bio to create a scalable, cost-effective, and accessible platform for the manufacturing and characterization of AAV-based gene therapy vectors Project developed with award from NIIMBL and financial assistance from the National Institute of Standards and Technology SPRING HOUSE, Pa. and WATERTOWN, Mass. — ChromaTan Inc., and Landmark Bio PBLLC, today announced they have been […]
Aptco Group has entered into a strategic partnership with Tilleghem, a private equity investment company based in Ghent, Belgium, whereby Tilleghem has acquired a minority stake in Aptco Group. This collaboration marks a significant step in Aptco Group’s growth trajectory, positioning the company for accelerated international expansion and long-term success. The daily operations and responsibilities […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
